Chromo Laboratories India Private Ltd, based in India, is a pharmaceutical company.
One of their notable products is ATORVASTATIN CALCIUM TRIHYDRATE USP, with a corresponding US DMF Number 33584.
Remarkably, this DMF maintains an Active status since its submission on March 05, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2022, and payment made on January 10, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II